Navigation Links
Newly approved brain stimulator offers hope for individuals with uncontrolled epilepsy
Date:4/22/2014

(Chicago) A recently FDA-approved device has been shown to reduce seizures in patients with medication-resistant epilepsy by as much as 50 percent. When coupled with an innovative electrode placement planning system developed by physicians at Rush, the device facilitated the complete elimination of seizures in nearly half of the implanted Rush patients enrolled in the decade-long clinical trials.

That's good news for a large portion of the nearly 400,000 people in the U.S. living with epilepsy whose seizures can't be controlled with medications and who are not candidates for brain surgery.

Epilepsy is a chronic neurological condition characterized by recurrent seizures that disrupt the senses, or can involve short periods of unconsciousness or convulsions. "Many people with epilepsy have scores of unpredictable seizures every day that make it impossible for them to drive, work or even get a good night's sleep," said Dr. Marvin Rossi, co-principal investigator of the NeuroPace Pivotal Clinical Trial and assistant professor of neurology at the Rush Epilepsy Center.

The NeuroPace RNS System uses responsive, or 'on-demand' direct stimulation to detect abnormal electrical activity in the brain and deliver small amounts of electrical stimulation to suppress seizures before they begin.

The device is surgically placed underneath the scalp within the skull and connected to electrodes that are strategically placed within the brain where the seizures originate (called the seizure focus). A programmed computer chip in the skull communicates with the system to record data and to help regulate responsive stimulation.

The unique electrode placement planning modeling system developed at Rush uses a computer-intensive mapping system that facilitates surgical placement of electrodes at the precise location in the brain's temporal lobe circuitry. When stimulated, these extensive epileptic circuits are calmed.

The modeling system predicts where in the brain the activity begins and spreads, so that the device can better influence the maximal extent of the epileptic pathway.

The device also acts as an implanted EEG for recording brain activity. This function was first shown at Rush to help determine whether the patient will further benefit from a surgical resection, in which surgeons remove a portion of the temporal lobe network.

Dr. Richard Byrne, chairman of Neurosurgery at Rush, implants the electrodes in the temporal lobes. As a result, physicians at Rush can offer patients the new implantable neurostimulator device, a surgical resection or both with the possibility of completely eliminating seizures. "This device is also being used at Rush as a foundation and inspiration for building cutting-edge hybrid stimulation therapy-drug molecule delivery systems," said Rossi.

"Devices that treat epilepsy may offer new hope to patients when medication is ineffective and resection is not an option," said Rossi. "Not long ago, it was highly unlikely that these patients would ever be free of their seizures. Now, several of our Rush patients with this device are actually able to drive, lower or even eliminate their medications and aren't as limited as they once were. There is no doubt that quality of life of the majority of our implanted patients is significantly improved."

According to the Centers for Disease Control and Prevention, in 2010, epilepsy affected approximately 2.3 million adults in the U.S. and 467,711 children under the age of 17.


'/>"/>

Contact: Nancy DiFiore
nancy_difiore@rush.edu
312-942-5159
Rush University Medical Center
Source:Eurekalert

Related medicine news :

1. Mayo Clinic offers newly approved treatment for acid reflux disease
2. Newly Aggressive Dogs May Be Reacting to Pain
3. Study: 21 percent of newly admitted nursing home residents sustain a fall during their stay
4. Moffitt Cancer Center melanoma expert reviews unique adverse events with newly approved drug
5. Newly insured patients may have trouble finding primary care physicians
6. Newly Released ProSkin 2.0 and ProMood Final Cut Pro X Plugins at Pixel Film Studios
7. The Newly Updated "The Diet Solution Program" Helps People Lose Body Fat, Says Health Review Center
8. Neurological Wellness Center's Novel Neuro-Inflammation Inhibition Procedure that Induces Rapid Recovery from Alzheimer's, Stroke and Brain Injury is Now Being Taught in a Newly Released Video
9. Newly Released “H Miracle” Can Teach People How to Cure Hemorrhoids, Says Health Review Center
10. Newly Launched Blenderreviews101.com - The Best and Complete Resource for Blender Reviews
11. Newly Updated 'Critical Bench' Teaches People How to Gain Muscle, Says Tony Nguyen
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2016)... PA (PRWEB) , ... December 02, 2016 , ... ... and pharmaceutical organizations to build intelligent, connected applications, was named the best Sales ... , The winner announcement was made today by the Software & Information ...
(Date:11/30/2016)... ... November 30, 2016 , ... ... we have been designated as a Cigna Infertility Center of Excellence. The Cigna ... standards. , “It’s an honor to be designated a Cigna Infertility Center ...
(Date:11/30/2016)... ... November 30, 2016 , ... Standard Process, Inc. is proud ... and recognition of the largest closely held companies headquartered in Wisconsin. This marks ... addition, Standard Process was awarded the Talent Award for providing outstanding employee benefits. ...
(Date:11/30/2016)... ... 2016 , ... In recent policy debates, increasing costs of ... and system stakeholders in many states. To help them understand this growth, today ... Workers’ Compensation, Eighth Edition (MPI-WC) . , “If you are a policymaker or ...
(Date:11/30/2016)... Arizona (PRWEB) , ... November 30, 2016 , ... ... Associates, has expanded its orthopedic practice with the addition of new North Phoenix ... Honor Health John C. Lincoln North Mountain campus at 9327 North 3rd St, ...
Breaking Medicine News(10 mins):
(Date:12/2/2016)... YORK , December 2, 2016 ... Research titled "Global Market Study on Automated Endoscope Reprocessors: Single ... a CAGR of 8.6% Between 2016 and 2024 " the global automated ... and is expected to expand at a CAGR of 7.2% ... valuation of US$ 1,367.6 Mn by 2024. ...
(Date:12/2/2016)... , Dec. 2, 2016 Quantum Radiology,s Mobile ... expert radiologist interpretation directly to women at the workplace, ... corporations, such as Delta Air Lines and SunTrust Bank, ... as a component of wellness initiatives. "I ... SunTrust. It enables them to have a mammogram without ...
(Date:12/2/2016)... 2016 On Thursday, December 1st ... in research, development and innovation in the biopharmaceutical industry ... held in the presence of Sergey Tsyb, Vice Minister ... Federation , Natalia Sanina, First Vice Chairman of ... Head of Roszdravnadzor, National Service of Control in Healthcare, ...
Breaking Medicine Technology: